ClinicalTrials.gg
CompletedNCT00967486Updated Sep 16, 2026Results posted

Selective Versus Routine Shunting in Carotid Endarterectomy Patients

An interventional study of Carotid endarterectomy with routine shount and Carotid endarterectomy with selective shunt in Stenoses, Carotid Artery, sponsored by CAMC Health System. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by CAMC Health System · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The project involves prospectively randomizing patients to either routine carotid shunting or selective carotid shunting during Carotid endarterectomy (CEA) under general anesthesia (GA) to see the difference in post-op complications and occurence rates. Patients will be randomized to Routine shunt vs selective groups.

Read the detailed description

The significance extends to all surgeons who perform Carotid endarterectomy because of their desire to improve patient care by decreasing the overall perioperative complication rate of the procedure by selectively not shunting those patients who ideally do not require it and thus eliminating the attendant morbidity associated with it.

The hypothesis is that there will be no difference in patient outcomes (death, minor strokes, major strokes, transient ischemic attack (TIA)) for patients undergoing a Carotid endarterectomy with a SP of > 50 mm Hg using selective shunting.Patients will be randomized to Routine shunt vs selective groups. In Selective shunt, there will be subgroup analysis to measure % stenosis if the systolic pressure is \< 40mmHg calling it as Shunt group. All patients in the study, irrespective of treatment group will be followed post-operatively from 24 hours to 30 days. The patient will be monitored and the following outcomes documented - death, minor stroke, major stroke, trans-ischemic attack (TIA).

02

Conditions studied

  • Stenoses, Carotid Artery

Browse trials for

03

In context

Carotid Stenosis

364 studies on the registry are indexed under Carotid Stenosis; 85 are open to participants now.

This study's enrollment of 200 is above the median of 103 across 189 interventional studies indexed under Carotid Stenosis.

Browse Carotid Stenosis studies →

Lead sponsor

CAMC Health System is the lead sponsor of 47 studies on the registry; 3 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a SP >= 50 mmHg will be randomized to receive a shunt or not receive a shunt.

Exclusion criteria

Exclusion Criteria:

  • Patients that will be excluded are those who present for a redo CEA, have had a coronary artery bypass graft (CABG), permanent stroke, and or a contralateral artery total occlusion of > 30%.
  • Finally, consented patients with a stump pressure of \<= 50 mm Hg will be excluded from the study and receive standard of care.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    Routine Shunt

    These patients are called routine as the routine method of carotid endarterectomy is used.

    Procedure: Carotid endarterectomy with routine shount

  • Active comparator
    Selective Shunt

    These patients are selectively used for shunting or not shunting based on systolic pressure \< 40mmHg. This group is further used as subgroup analysis.

    Procedure: Carotid endarterectomy with selective shunt

Interventions

  • ProcedureCarotid endarterectomy with routine shount
  • ProcedureCarotid endarterectomy with selective shunt
06

What researchers measure

Primary outcomes

  1. Overall Perioperative Complications Between Selective vs. Routine Shunting.

    perioperative complication included at least one of transient ischemic attack (TIA), hemorrhage, myocardial infarction \[MI\], or asymptomatic carotid thrombosis or congestive heart failure.

    Time frame: Within 30 days of enrollment

07

Results

Posted Oct 24, 2013

Participant flow

Participant flow — Overall Study
MilestoneRoutine ShuntSelective Shunt
Started98102
Completed98102
Not completed00

Outcome measures

PrimaryOverall Perioperative Complications Between Selective vs. Routine Shunting.

perioperative complication included at least one of transient ischemic attack (TIA), hemorrhage, myocardial infarction \[MI\], or asymptomatic carotid thrombosis or congestive heart failure.

Time frame:
Within 30 days of enrollment
Reported as:
Number · Participants
Overall Perioperative Complications Between Selective vs. Routine Shunting.
ParticipantsRoutine ShuntSelective Shunt
Overall Perioperative Complications Between Selective vs. Routine Shunting.78
Statistical analysis
  • Routine Shunt vs Selective Shunt · Fisher Exact · p = <0.05

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Routine Shunt0/98 (0%)0/98 (0%)0/98 (0%)
Selective Shunt1/102 (1%)1/102 (1%)0/102 (0%)
Most frequent serious events
Most frequent serious events
EventRoutine ShuntSelective Shunt
StrokeNervous system disorders—1/102

Baseline characteristics

Age, Customized
Age, Customized(participants)Routine ShuntSelective ShuntTotal
Between 18 and 65 years384482
>=65 years6058118
Age, Continuous
Age, Continuous(years)Routine ShuntSelective ShuntTotal
Mean68.78 ± 9.0867.29 ± 9.8168.02 ± 9.46
Sex: Female, Male
Sex: Female, Male(Participants)Routine ShuntSelective ShuntTotal
Female5053103
Male484997
Region of Enrollment
Region of Enrollment(participants)Routine ShuntSelective ShuntTotal
United States98102200
08

Study locations

1 site
  • (Vascular Center of Excellence)
    Charleston, West Virginia 25304, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2006, a primary completion of Jun 2009 and a completion of Jun 2009. It does not say whether these dates are actual or estimated.

Results were first posted in Oct 2013, 4 years 4 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2009
First posted
Aug 28, 2009
Start
Dec 2006
Primary completionActual
Jun 2009
CompletionActual
Jun 2009
Results first posted
Oct 24, 2013
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00967486
Lead sponsor
CAMC Health System
Responsible party
Sponsor
First posted
Aug 28, 2009
Start date
Dec 2006
Primary completion
Jun 2009
Completion
Jun 2009
Results posted
Oct 24, 2013
Last update
Sep 16, 2026

Study contacts

Ali F AbuRhama, M.D.
principal investigator · CAMC Medical Staff - with admitting privileges

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion